[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
February 1978

Cutaneous Toxicity

Author Affiliations

San Francisco

 

edited by Victor A. Drill, and Paul Lazar, 277 pp, with illus, $14.50, New York, Academic Press Inc, 1977.

Arch Dermatol. 1978;114(2):306. doi:10.1001/archderm.1978.01640140102041

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

DIPROSONE® brand of betamethasone dipropionate Cream 0.05%, Ointment 0.05%, Lotion 0.05% w/w, Aerosol 0.1% w/w (Potency expressed as betamethasone) For Dermatologic Use Only ACTIONS: DIPROSONE Cream, Ointment, Lotion, and Aerosol are primarily effective because of their anti-inflammatory, antipruritic, and vasoconstrictive actions. INDICATIONS: DIPROSONE Cream, Ointment, and Lotion are indicated for the relief of the inflammatory manifestations of corticosteroid-responsive dermatoses. DIPROSONE Aerosol is indicated solely for the adjunctive topical management for the relief of inflammatory manifestations of acute contact dermatitis. DIPROSONE Aerosol has not been shown to be effective in any steroid-responsive dermatosis other than contact dermatitis. CONTRAINDICATIONS: DIPROSONE Cream, Ointment, Lotion, and Aerosol are contraindicated in vaccinia and varicella. Topical steroids are contraindicated in those patients with a history of hypersensitivity to any of the components of such preparations. DIPROSONE Aerosol is also contraindicated for use under occlusive dressings. WARNINGS FOR DIPROSONE AEROSOL: Keep DIPROSONE Aerosol away from eyes or

First Page Preview View Large
First page PDF preview
First page PDF preview
×